https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-rss/?orgId=115111&title=Latest+News A selection of the latest research, academic, and other newsworthy developments at Pusztai Lab en-us Copyright 2026 Yale School of Medicine Thu, 14 May 2026 20:46:54 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/calculating-cancer-risk-through-the-genetic-fingerprints-of-tumors/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/calculating-cancer-risk-through-the-genetic-fingerprints-of-tumors/ A new tool offers insights into understanding why every patient has a unique cancer journey. Fri, 08 May 2026 14:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/lajos-pusztai-md-dphil-named-a-giant-of-cancer-carer/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/lajos-pusztai-md-dphil-named-a-giant-of-cancer-carer/ OncLive®, the nation’s leading multimedia resource for oncology professionals, is pleased to announce the winners of the 14th annual Giants of Cancer Care® awards. Fri, 08 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/dr-sarah-schellhorn-named-fellow-of-the-american-society-of-clinical-oncology/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/dr-sarah-schellhorn-named-fellow-of-the-american-society-of-clinical-oncology/ Sarah Schellhorn, MD, associate professor of medicine (medical oncology and hematology) and chief of Ambulatory Services at Smilow Cancer Hospital, has been named a Fellow of the American Society of Clinical Oncology (FASCO). Thu, 09 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/standout-research-clinical-care-and-staff-support-recognized/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/standout-research-clinical-care-and-staff-support-recognized/ A dozen awards honored 15 people at January's Yale Cancer Center Annual Awards for work in 2025. Wed, 28 Jan 2026 05:00:00 Z https://ascopubs.org/do/association-between-eol-sact-and-healthcare-utilization https://ascopubs.org/do/association-between-eol-sact-and-healthcare-utilization Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article "Association Between Systemic Anticancer Therapy Administration Near the End of Life with Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality,” highlighting adverse outcomes for patients who receive any type of systemic anticancer therapy (SACT) at EOL (End of Life) and the need for better communication between oncologists and patients regarding expected risk and benefits of such treatments to properly align goals-of-care. Thu, 08 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/aging-and-cancer-joint-retreat-report/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/aging-and-cancer-joint-retreat-report/ The Aging and Cancer Research Joint Retreat, in October 2025, brought together researchers, clinicians, and community leaders to address the growing challenges of cancer care in an aging population. Co-hosted by Yale Cancer Center and the Agency on Aging of South Central Connecticut, the retreat will result in a Cancer & Aging Research Alliance. Mon, 05 Jan 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-research-advances-presented-at-san-antonio-breast-cancer-symposium-annual-meeting/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-research-advances-presented-at-san-antonio-breast-cancer-symposium-annual-meeting/ Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center attended the 48th annual San Antonio Breast Cancer Symposium (SABCS), from December 9-12, 2025. Sat, 13 Dec 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-to-present-breakthrough-breast-cancer-research-at-international-conference-in-texas/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-to-present-breakthrough-breast-cancer-research-at-international-conference-in-texas/ At SABCS, Yale Cancer Center experts will present groundbreaking research on hormone replacement therapy in breast cancer care, innovative treatment options for HER2-positive and hormone receptor-positive breast cancers, and the impact of patient-centered approaches to care. Mon, 01 Dec 2025 12:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/ycc-publlications-2025/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/ycc-publlications-2025/ Publications regarding cancer attributed to first- and last-authors of published papers Mon, 27 Oct 2025 16:00:00 Z https://www.curetoday.com/view/improving-end-of-life-care-making-hospice-and-home-support-accessible https://www.curetoday.com/view/improving-end-of-life-care-making-hospice-and-home-support-accessible Experts discuss how better hospice and home care reimbursement can help patients receive compassionate end-of-life care at home. Wed, 22 Oct 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/radiating-hope-celebrating-life-smilow-cancer-hospital-and-yale-cancer-centers-cancer-survivors-day/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/radiating-hope-celebrating-life-smilow-cancer-hospital-and-yale-cancer-centers-cancer-survivors-day/ On June 5, 2025, members of Smilow Cancer Hospital and Yale Cancer Center gathered for the annual Cancer Survivors Day Celebration. The event, titled, "Radiating Hope, Celebrating Life" featured inspirational speakers and breakout sessions focused on supporting cancer survivors and their families. Mon, 09 Jun 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-researchers-and-trainees-present-at-2025-asco-annual-meeting/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-researchers-and-trainees-present-at-2025-asco-annual-meeting/ Researchers from Yale Cancer Center participated in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago from May 30 to June 3, where they presented the latest research advancements from Yale Cancer Center and Smilow Cancer Hospital. Fri, 06 Jun 2025 04:00:00 Z https://www.wtnh.com/news/health/celebrating-national-cancer-survivorship-month/ https://www.wtnh.com/news/health/celebrating-national-cancer-survivorship-month/ In today’s WTNH health headlines, we celebrate National Cancer Survivorship Month. There are more than 18 million cancer survivors in the U.S., which is about 5 percent of the population. Dr. Tara Sanft, medical director of the survivorship clinic for Smilow Cancer Hospital and Yale Cancer Center, joined Good Morning Connecticut at 9 a.m. to discuss. Thu, 05 Jun 2025 04:00:00 Z https://www.statnews.com/2025/06/04/cancer-blood-tests-oncologists-see-liquid-biopsy-potential-want-more-data-ctdna-testing/ https://www.statnews.com/2025/06/04/cancer-blood-tests-oncologists-see-liquid-biopsy-potential-want-more-data-ctdna-testing/ Tests searching for tumor DNA that’s circulating in the blood are surging in popularity, because they can clue clinicians into what’s happening with a patient’s cancer long before any changes appear on more traditional tools like MRI or CT scans. Dr. Lajos Pusztai, a breast cancer researcher and co-Director of the Cancer Center Genomics, Genetics, and Epigenetics Program at Yale Cancer Center, spoke with STAT News reporter, Angus Chen. Wed, 04 Jun 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-experts-set-to-present-advances-in-cancer-research-at-the-worlds-largest-clinical-oncology-conference/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-experts-set-to-present-advances-in-cancer-research-at-the-worlds-largest-clinical-oncology-conference/ Over 40 Yale Cancer Center researchers will share advances for new therapies at the 2025 ASCO Annual Meeting with research areas covering breast, lung, prostate, head and neck, early onset, and metastatic cancers. Wed, 14 May 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/internal-medicine-promotions-appointments-may-2025/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/internal-medicine-promotions-appointments-may-2025/ Congratulations to the Yale Department of Internal Medicine faculty members who were recently promoted, appointed, or reappointed. Tue, 06 May 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/fertility-preservation-for-breast-cancer-patients/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/fertility-preservation-for-breast-cancer-patients/ Sarah Schellhorn was recently a guest on Yale Cancer Answers, the Connecticut Public Radio program hosted by Eric Winer, director of the Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital. Drs. Winer and Schellhorn, both breast cancer specialists, discussed the latest research and its implications for post-cancer fertility, pregnancy and survivorship. Mon, 10 Mar 2025 11:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/cancer-survivorship-committed-support/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/cancer-survivorship-committed-support/ Dr. Tara Sanft, director of the Smilow Survivorship Clinic at Yale Cancer Center and Smilow Cancer Hospital, recently appeared on Yale Cancer Answers with host Dr. Eric Winer, director of the Yale Cancer Center to discuss support for cancer patients and how that has evolved. Mon, 17 Feb 2025 13:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-answers-50-year-of-cancer-progress-survivorship/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-answers-50-year-of-cancer-progress-survivorship/ February 2, 2025 | Dr. Tara Sanft Mon, 03 Feb 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/dr-sarah-schellhorn-on-yale-cancer-answers-cancer-risks-and-the-role-of-patient-decision-making/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/dr-sarah-schellhorn-on-yale-cancer-answers-cancer-risks-and-the-role-of-patient-decision-making/ Dr. Sarah Schellhorn on Yale Cancer Answers. Mon, 06 Jan 2025 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-presents-advances-in-breast-cancer-at-the-san-antonio-breast-cancer-symposium/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-presents-advances-in-breast-cancer-at-the-san-antonio-breast-cancer-symposium/ Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center joined more than 11,000 physicians, scientists, and trainees focused on advancing research and clinical care in breast cancer attending the annual San Antonio Breast Cancer Symposium December 10-14, 2024. The Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers. Tue, 17 Dec 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/advancing-breast-cancer-research-yale-cancer-center-to-share-insights-at-international-conference/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/advancing-breast-cancer-research-yale-cancer-center-to-share-insights-at-international-conference/ Yale Cancer Center experts will discuss a variety of topics at SABCS ranging from novel therapeutics for HER2+ breast cancers, dosing optimization in breast cancer trials, and new findings on different genomic ancestries for advanced breast cancers. Tue, 26 Nov 2024 05:00:00 Z https://www.healio.com/news/hematology-oncology/20241104/strategies-needed-to-reduce-death-due-to-lowrisk-breast-cancer https://www.healio.com/news/hematology-oncology/20241104/strategies-needed-to-reduce-death-due-to-lowrisk-breast-cancer “Drug development efforts and all the improvements in breast cancer death are really happening in the high-risk stage II and stage III disease setting,” Lajos Pusztai, MD, DPhil, medical oncologist and co-director of the genomics, genetics and epigenetics program at Yale Cancer Center, told Healio. Wed, 06 Nov 2024 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/smilow-shares-breast-cancer-awareness-empowered-through-knowledge-smilow-at-guilford/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/smilow-shares-breast-cancer-awareness-empowered-through-knowledge-smilow-at-guilford/ On October 30, 2024, members of the Center for Breast Cancer in Guilford presented in honor of National Breast Cancer Awareness Month. Thu, 31 Oct 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/living-flat-study-sheds-light-on-challenges-for-women-of-color-after-breast-cancer-surgery/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/living-flat-study-sheds-light-on-challenges-for-women-of-color-after-breast-cancer-surgery/ In the study titled, "Living Flat: Stories from Women of Color After Mastectomy," published in Annals of Surgical Oncology on October 15, Yale Cancer Center researchers at Yale School of Medicine explain how cultural factors, spirituality, and personal beliefs play an important role in the lives of women of color after mastectomies. Mon, 28 Oct 2024 04:00:00 Z https://www.medscape.com/viewarticle/popular-weight-loss-drugs-now-patients-cancer-2024a1000hqy https://www.medscape.com/viewarticle/popular-weight-loss-drugs-now-patients-cancer-2024a1000hqy Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes. But data on the practice remain limited. Mon, 30 Sep 2024 04:00:00 Z https://www.onclive.com/view/dr-pusztai-on-molecular-residual-disease-monitoring-in-early-breast-cancer https://www.onclive.com/view/dr-pusztai-on-molecular-residual-disease-monitoring-in-early-breast-cancer Dr. Lajos Pusztai on Molecular Residual Disease Monitoring in Early Breast Cancer Mon, 08 Jul 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/oncology-hospitalists-improve-hospice-transitions-advanced-cancer-patients/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/oncology-hospitalists-improve-hospice-transitions-advanced-cancer-patients/ Unplanned hospitalizations for patients with advanced cancer often trigger discussions about care goals and transitions to hospice. Late referrals to hospice, particularly near the end of life, have been associated with reduced quality of life and increased healthcare costs. A new research study published in Cancer investigates the impact of oncology hospitalists on the timing of hospice transitions for patients with advanced cancers. Mon, 11 Mar 2024 04:00:00 Z https://www.hmpgloballearningnetwork.com/site/onc/conference-coverage/ctdna-monitoring-patients-er-positive-her2-negative-high-risk-breast https://www.hmpgloballearningnetwork.com/site/onc/conference-coverage/ctdna-monitoring-patients-er-positive-her2-negative-high-risk-breast Lajos Pusztai, MD, DPhil, from Yale Cancer Center discussed results at SABCS from the DARE study which analyzed the clinical utility of ctDNA monitoring during adjuvant endocrine therapy to detect molecular relapse before apparent recurrence. Fri, 05 Jan 2024 05:00:00 Z https://insights.som.yale.edu/podcasts/health-veritas/tara-sanft-life-after-cancer https://insights.som.yale.edu/podcasts/health-veritas/tara-sanft-life-after-cancer Howie and Harlan are joined by Tara Sanft, chief patient experience officer at Yale’s Smilow Cancer Hospital and director of the Survivorship Program at the Yale Cancer Center. Thu, 07 Dec 2023 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/study-patients-genetic-characteristics-may-help-differentiate-her2-low-advanced-breast-cancers-and-guide-treatment-selection/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/study-patients-genetic-characteristics-may-help-differentiate-her2-low-advanced-breast-cancers-and-guide-treatment-selection/ In a new study led by Yale Cancer Center researchers at Yale School of Medicine, their findings revealed important differences in the genetic makeup of HER2-low advanced breast cancers — a discovery that could lead to better treatment options for patients. Wed, 06 Dec 2023 05:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/smilow-shares-cme-perspectives-on-the-uspstf-breast-screening-recommendations/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/smilow-shares-cme-perspectives-on-the-uspstf-breast-screening-recommendations/ On Tuesday, September 19, 2023, experts from Smilow Cancer Hospital and Yale Cancer Center shared: Perspectives on the USPSTF Breast Screening Recommendations. Wed, 20 Sep 2023 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/drs-veda-giri-and-lajos-pusztai-named-fellows-of-the-american-society-of-clinical-oncology/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/drs-veda-giri-and-lajos-pusztai-named-fellows-of-the-american-society-of-clinical-oncology/ Veda Giri, MD, Chief of Clinical Cancer Genetics and Co-Director of the Early Onset Cancer Program at Smilow Cancer Hospital and Yale Cancer Center, and Lajos Pusztai, MD, DPhil, Professor of Medicine (Medical Oncology), have been named Fellows of the American Society of Clinical Oncology (FASCO). Mon, 18 Sep 2023 04:00:00 Z https://www.targetedonc.com/view/pembrolizumab-shows-efs-benefit-in-tnbc-without-complete-response https://www.targetedonc.com/view/pembrolizumab-shows-efs-benefit-in-tnbc-without-complete-response Lajos Pusztai, MD, DPhil, discusses key takeaways from analysis of the KEYNOTE-522 clinical trial of pembrolizumab plus chemotherapy in the neoadjuvant or adjuvant setting for patients with triple-negative breast cancer. Thu, 27 Oct 2022 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-researchers-awarded-grants-by-breast-cancer-research-foundation/ https://websites4-live-prod.ysmdevs.com/lab/pusztai/news-article/yale-cancer-center-researchers-awarded-grants-by-breast-cancer-research-foundation/ The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its 2022 research grants, including six funded grants at Yale Cancer Center and Smilow Cancer Hospital awarded to Mehra Golshan, MD, MBA, Melinda Irwin, PhD, MPH, Ian Krop, MD, PhD, Lajos Pusztai, MD, DPhil, David Rimm, MD, PhD, and Eric Winer, MD to support their research. Mon, 22 Aug 2022 04:00:00 Z https://www.aacr.org/about-the-aacr/newsroom/news-releases/benefits-of-pre-surgical-immunotherapy-were-independent-of-race-in-patients-with-aggressive-breast-cancer/ https://www.aacr.org/about-the-aacr/newsroom/news-releases/benefits-of-pre-surgical-immunotherapy-were-independent-of-race-in-patients-with-aggressive-breast-cancer/ Treatment outcomes were similar between Black and non-Black patients with triple-negative breast cancer who received neoadjuvant durvalumab (Imfinzi) plus chemotherapy, according to phase I/II clinical trial results published in Clinical Cancer Research, a journal of the American Association for Cancer Research. Fri, 29 Jul 2022 04:00:00 Z